Raludotatug is a humanized immunoglobulin G1-kappa (IgG1kappa) monoclonal antibody that exhibits antineoplastic properties through its specific targeting of cadherin-6 (CDH6), and when conjugated to a cytotoxic payload to form the antibody-drug conjugate Raludotatug deruxtecan.Raludotatug has demonstrated promising research potential in heavily pretreated, platinum-sensitive ovarian cancer.
Reinheit:
98.70%
CAS Nummer:
[2610074-56-9]
Target-Kategorie:
ADC Antibody|||Cadherin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten